Flavoxate
Dosages; See below
Combinations; See below
Flavoxate Brands
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| UPSA-CUraxil-Fort | Pacific Pharmaceuticals Ltd | Globe Pharmacy Ltd., | 200mg | 30 | Tablet | per tablet | KES 676.5 |
| UPSA-CUraxil-Fort | Pacific Pharmaceuticals Ltd | Globe Pharmacy Ltd., | 10 | effervescent tablets | KES 146 | ||
| Urispas | Syntex Pharmaceuticals | C.Mehta & Co Ltd. | 200mg | 30 | Tablet | per tablet | KES 672 |
| Uraxil-Fort | Globe Pharmacy Ltd., | Globe Pharmacy Ltd., | 200mg | 30 | Tablet | per tablet | KES 676.50 |
| Flavoxate More info | |
|---|---|
| Mode Of Action | Flavoxate and oxybutynin have direct antispasmodic effects on smooth muscle, especially of the urinary tract. They also have weak antihistaminic effect, local anaesthetic, analgesic and weak anticholinergic properties at higher doses. |
| Drug Indication | Urinary frequency and incontinence dysuria; urgency and bladder spasms due to catheterization |
| Precautions | Myasthenia gravis; renal and hepatic impairment; pregnancy and lactation; elderly; diarrhoea; glaucoma; hypertension; ulcerative colitis; Down syndrome |
| Contra-Indications | Prostate enlargement; paralytic ileus; pyloric stenosis; high ambient temperatures |
| Side Effects | Anticholinergic SE: dry mouth /skin; difficult in swallowing; visual disturbances; flushings; constipation; difficult in micturation. Drowsiness; arrhythmias |
| Dosage | 200mg TID. |
| Pregnancy Category | Category B: |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Categorized further into: |
| Drug Category | DRUGS ACTING ON GENITO-URINARY SYSTEM |
| Drug Sub-Category | Other genito-urinary acting drugs |